BofA raised the firm’s price target on Fortrea Holdings to $29 from $26 and keeps an Underperform rating on the shares after the company reported Q3 results. The firm believes the stock has potential, but it will take time to be realized. Overall, BofA thinks Fortrea will fare better as a standalone.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FTRE:
- Fortrea Holdings sees 2023 revenue $3.075B-$3.13B, consensus $3.07B
- Fortrea Holdings reports Q3 adjusted EPS 24c, consensus 16c
- Fortrea Reports Third Quarter 2023 Results
- Fortrea Holdings Inc. (FTRE) Q3 Earnings Cheat Sheet
- TC Biopharm selects Fortrea as contract research organization for global trials